Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Foundation (DNRF) for an initial period of 6 years (2023–2028), with the possibility of a 4-year extension. The center is led by Professor N. Asger Mortensen and currently consists of two Associate Professors
-
/forskning/cim and contact Associate Professor Lars Duggen, Head of Centre for Industrial Mechanics, tel. +45 6550 1640, e-mail: duggen@sdu.dk or Associate Professor Ali Khosravi, tel. +45 6550 1887, e-mail
-
), please contact PhD coordinator, Associate Professor Niels Skovmand Rasmussen at nsr@sam.sdu.dk. Please note that due to holidays, responses to inquiries cannot be expected in the month of July. Application
-
Job Description A 3-year fully funded PhD stipend for studying the gene-regulatory mechanisms that control cancer biology at single-cell resolution is available in the group of Associate Professor
-
, Associate Professor, Lykke Margot Ricard, e-mail: Lmri@iti.sdu.dk, phone: (+45) 65 50 86 81. If you experience technical problems, please contact hcm-support@sdu.dk. Application procedure Before applying
-
Associate Professor Ramkrishan Maheshwari, phone: +45 65 50 16 86, email: ramkrishan@sdu.dk If you experience technical problems, please contact hcm-support@sdu.dk . Application procedure Applicants
-
including pension) and excellent conditions to excel in their research. Further information is available Associate Professor Ramkrishan Maheshwari, phone: +45 65 50 16 86, email: ramkrishan@sdu.dk If you
-
involved in the daily supervision of master and bachelor students. You will publish and present your work both at international conferences and in scientific journals with high impact. You will assist in
-
information about the position, please contact Professor Lars Frederiksen, Email: L.Frederiksen@mgmt.au.dk Who we are The Department of Management is one of the six departments at Aarhus BSS, one of the five
-
function, and dysfunction of these proteins has vast implications for a wide range of brain diseases. In this project the fellow will explore the development of peptide-based compounds targeting aberrant